This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: Rucaparib +/- Nivo as Maintenance in Newly Diagnosed Ovarian Cancer - ATHENA-COMBO Ph3 Trial

258 views
September 19, 2024
Comments 0
Login to view comments. Click here to Login